Journals / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 5

Memantine and Q-VD-OPh Treatments in Experimental Spinal Cord Injury: Combined Inhibition of Necrosis and Apoptosis

Pages
783–789
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The combined inhibition of the two major pathways, necrosis and apoptosis, needs to be further assessed with in-vivo or in-vitro studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To evaluate the effects of NMDA receptor antagonist memantine and pancaspase inhibitor Q-VD-Oph in combination or alone in experimental spinal cord injury.
📊
Key Findings & Data:MATERIAL and METhODS: 45 male Sprague-Dawley rats were divided into five groups.
💡
Conclusion & Impact:The combined inhibition of the two major pathways, necrosis and apoptosis, needs to be further assessed with in-vivo or in-vitro studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: To evaluate the effects of NMDA receptor antagonist memantine and pancaspase inhibitor Q-VD-Oph in combination or alone in experimental spinal cord injury. MATERIAL and METhODS: 45 male Sprague-Dawley rats were divided into five groups. Spinal cord injury was created with the clip compression technique. The drugs were administered either alone of in combination to the subjects according to their groups. Motor function was assessed with Tarlov's motor grading scale and the inclined plane technique. The subjects were sacrificed at the fifth postoperative day. Histopathological examination was done with the use of hematoxylin eosin and TUNEL staining. RESULTS: The results for TUNEL staining and apoptotic cell counts revealed statistically significant differences in Q-VD-Oph and combined treatment groups. Tarlov motor grading scale and inclined plane test results were also found significantly better in these two groups. CONCLUSION: Combined use of memantine and Q-VD-OPh provides better histological and clinical results. The combined inhibition of the two major pathways, necrosis and apoptosis, needs to be further assessed with in-vivo or in-vitro studies.

🔖

Cite This Article

AYDOSELİ, A., CAN, H., ARAS, Y., SABANCI, P. A., AKCAKAYA, M. O., ÜNAL, Ö. F. (2016). Memantine and Q-VD-OPh Treatments in Experimental Spinal Cord Injury: Combined Inhibition of Necrosis and Apoptosis. Turkish Neurosurgery, Cilt: 26 - Sayı: 5, 783–789. https://ajindex.com/articles/404726

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL: Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 8: 345-352, 2003 2. Choi DW, Maulucci-Gedde M, Kriegstein AR: Glutamate neurotoxicity in cortical cell culture. J Neurosci 7:357-368, 1987 3. Colak A, Karaoglan A, Barut S, Kokturk S, Akyıldız AI, Tasyurekli M: Neuroprotection and functional recovery after application of the caspase 9 inhibitor z-LDH-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine 2(3): 327-334, 2005 4. Colak A, Antar V, Karaoglan A, Akdemir O, Sahan E, Celik O, Sagmanligil A: Q-VD-OPh, a pancaspase inhibitor reduces trauma induced apoptosis and improves the recovery of hindlimb function in rats after spinal cord injury. Neurocirugia 20: 533-540, 2009 5. Cummings MC, Winterford CM, Walker NI: Apoptosis. Am J Surg Pathol 21(1): 88-101, 1997 6. Dickens BF, Weglicki WB, Li YS, Mak IT: Magnesium deficiency in vitro enhances free radical induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 311:187-191, 1992 7. Dumont RJ, Verma S, Okonkwo DO, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS: Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol 24: 265-279, 2001 8. Ehrlich M, Knolle E, Ciovica R, Bock P, Turkof E, Grabenwöger M, Cartes-Zumelzu F, Kocher A, Pockberger H, Fang WC, Wolner E, Havel M: Memantine for prevention of spinal cord injury in a rabbit model. J Thorac Cardiovasc Surg 117(2): 285-291, 1999 9. Fujiki M, Furukawa Y, Kobayashi H, Abe T, Ishii K, Uchida S, Kamida T: Geranylgeranylacetone limits secondary injury, neuronal death, and progressive necrosis and cavitation after spinal cord injury. Brain Res 1053: 175-184, 2005 10. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Bio 119: 493-501, 1992 11. Gorgulu A, Kins T, Cobanoglu S, Unal F, Izgi NI, Yanik B, Kucuk M: Reduction of edema and infarction by memantine and MK- 801 after focal cerebral ischemia and reperfusion in rat. Acta Neurochir 142: 1287-1292, 2000 12. Guth L, Barrett CP, Donati EJ, Anderson FD, Smith MV, Lifson M: Essentiality of a specific cellular terrain for growth of axons into a spinal cord lesion, Exp. Neurol 88:1-12, 1985 13. Guth L, Zhang Z, Roberts E: Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury Proc Natl Acad Sci USA 91:12308 -12312, 19